SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001609351-18-000019
Filing Date
2018-02-20
Accepted
2018-02-20 07:50:29
Documents
2
Period of Report
2018-02-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K spark-20178kearnings.htm 8-K 37355
2 EXHIBIT 99.1 spark-exhibit991fullyear20.htm EX-99.1 139352
  Complete submission text file 0001609351-18-000019.txt   177931
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36819 | Film No.: 18623091
SIC: 2836 Biological Products, (No Diagnostic Substances)